Trial reportPM & R : the journal of injury, function, and rehabilitation2026
Toward personalizing prosthesis prescription: A take-home study of three microprocessor-controlled prosthetic knees: A randomized crossover study.
Trial report in PM & R : the journal of injury, function, and rehabilitation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06399471 (Personalizing MPK Prescription for Individuals With Transfemoral Amputation), which is not on this map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Personalizing MPK Prescription for Individuals With Transfemoral Amputation
Who cites it
3 citing papers in PubMed.
- Beyond microprocessor knees: exploring the potential of fully powered prosthetic legs.Journal of neuroengineering and rehabilitation · 2026Trial
- Toward personalizing prosthesis prescription: A take-home study of three microprocessor-controlled prosthetic knees: A randomized crossover study.PM & R : the journal of injury, function, and rehabilitation · 2026Trial
- Measuring satisfaction with orthotic and prosthetic devices.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundPrevious studies on microprocessor-controlled prosthetic knees (MPKs) often investigate benefits of MPKs as a class of knees rather than clinically relevant differences between specific knees, despite their distinct features.
objectivesTo systematically evaluate and report outcomes associated with three commercially available MPKs following a standardized real-world use period.
designRandomized crossover study.
settingResearch laboratory and community environment.
participantsTen patients with transfemoral amputation.
interventionsThree MPKs were fitted, trained, and worn for a 1-week period including C-Leg 4.0 (Ottobock, Duderstadt, Germany), Rheo Knee-Model RM7 (Össur, Reykjavik, Iceland), and Power Knee-PKA01 (Össur, Reykjavik, Iceland).
main outcome measuresPrimary outcomes were the 10-meter walk test (10-mwt), the 2-minute walk test (2-mwt), and the Prosthesis Evaluation Questionnaire (PEQ). Secondary outcomes were stance time asymmetry, physiological cost index, stair and ramp speeds, the narrowing beam walking test, and community ambulation monitoring.
resultsParticipants walked 11% faster in Rheo than Power Knee during the 10-mwt (95% confidence interval [CI]: 0.046-0.184, p = .015). In the 2-mwt, participants walked 12% faster in C-Leg (95% CI: 0.034-0.241, p = .003) and 9% faster in Rheo (95% CI: 0.031, 0.163, p = .027) than in Power Knee. On the PEQ, participants reported greater satisfaction with C-Leg compared to Power Knee (p = .006). Ramp ascent speed was 8% faster in Rheo than Power Knee (95% CI: 0.026-0.130, p = .024). No significant differences were found for other secondary outcomes. Notably, 10 of 12 outcomes showed individuals performing their best by a defined difference on an MPK different from the cohort's best-performing MPK.
conclusionsParticipants walked faster in C-Leg and Rheo than Power Knee and reported greater satisfaction with C-Leg. Consideration of patient needs and characteristics may allow more individualized MPK prescription and thereby improve rehabilitation outcomes. DATABASE REGISTRATION: NCT06399471.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.